Zobrazeno 1 - 10
of 863
pro vyhledávání: '"Daniel E. Furst"'
Autor:
Yukai Wang, Shaoqi Chen, Shaoyu Zheng, Zexuan Zhou, Weijin Zhang, Guangzhou Du, Angelina Mikish, Barbara Ruaro, Cosimo Bruni, Anna-Maria Hoffmann-Vold, Luna Gargani, Marco Matucci-Cerinic, Daniel E Furst
Publikováno v:
Arthritis Research & Therapy, Vol 26, Iss 1, Pp 1-11 (2024)
Abstract Systemic autoimmune rheumatic diseases (SARDs) related pulmonary disease is highly prevalent, with variable clinical presentation and behavior, and thus is associated with poor outcomes and negatively impacts quality of life. Chest high reso
Externí odkaz:
https://doaj.org/article/df30442c4ebe4e88999340266017ada4
Autor:
Khadija El Aoufy, Maria Ramona Melis, Paolo Iovino, Stefano Bambi, Chiara Lorini, Guglielmo Bonaccorsi, Ilaria Galetti, Carla Garbagnati, Paola Canziani, Silvia Tonolo, Marco Mitola, Serena Guiducci, Daniel E. Furst, Marco Matucci-Cerinic, Laura Rasero, Silvia Bellando-Randone
Publikováno v:
Nursing Reports, Vol 14, Iss 1, Pp 556-565 (2024)
Rationale and aim: Health literacy (HL) is pivotal for the successful self-management of chronic diseases. Little HL information is currently available in SSc patients; therefore, the present study aims at evaluating the HL levels in an Italian cohor
Externí odkaz:
https://doaj.org/article/f815d82495fc4115913d115e3b127fd5
Autor:
Christina Charles-Schoeman, Jon T. Giles, Nancy E. Lane, Ernest Choy, Daniel E. Furst, Jiří Vencovský, Anthony G. Wilson, Gerd R. Burmester, Derek Coombs, Sara K. Penn, Nasser Khan, Jillian B. Yee, Kassim Rahawi, Iain B. McInnes
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 1, Pp 157-175 (2024)
Abstract Introduction Upadacitinib (UPA) is a Janus kinase inhibitor that has demonstrated efficacy in moderate-to-severe rheumatoid arthritis (RA) with an acceptable safety profile. We investigated laboratory parameter changes in UPA RA clinical tri
Externí odkaz:
https://doaj.org/article/7848bcb7d51248bd8d20a0519b6de718
Autor:
Dinesh Khanna, Daniel E. Furst, Justin W. Li, Qian Meng, Yuan Yuan, Tamara Lesperance, Kenyatta Peoples, Farah Ali, Brian LaMoreaux, Stephanie D. Taylor
Publikováno v:
ACR Open Rheumatology, Vol 5, Iss 12, Pp 677-684 (2023)
Objective To describe the health care resource use (HCRU) and costs of patients with systemic sclerosis (SSc) prior to and after diagnosis. Methods This retrospective study used a claims data set (Merative MarketScan; 2015‐2019). Eligible patients
Externí odkaz:
https://doaj.org/article/b6f63ba73e5744dbbb31b7a2aef88f44
Autor:
Carmela Coccia, Francesco Bonomi, Anna Lo Cricchio, Edda Russo, Silvia Peretti, Giulia Bandini, Gemma Lepri, Francesca Bartoli, Alberto Moggi-Pignone, Serena Guiducci, Francesco Del Galdo, Daniel E. Furst, Marco Matucci Cerinic, Silvia Bellando-Randone
Publikováno v:
Biomedicines, Vol 12, Iss 8, p 1760 (2024)
The gut microbiota is a complex ecosystem of microorganisms residing in the human gastrointestinal tract, playing a crucial role in various biological processes and overall health maintenance. Dysbiosis, an imbalance in the composition and function o
Externí odkaz:
https://doaj.org/article/ea1395cdba20425698db0348cdd2a496
Autor:
Philip J Mease, Daniel E Furst, Jeffrey R Lisse, Christophe Sapin, Kirstin Griffing, Sarah Ross, Paulo Reis, Aisha Vadhariya, Soumya Reddy
Publikováno v:
RMD Open, Vol 10, Iss 1 (2024)
Introduction An important consideration in the treatment of patients with psoriatic arthritis (PsA) is whether the addition of methotrexate (MTX) to biologics has greater efficacy than biologic monotherapy with respect to efficacy outcomes in these p
Externí odkaz:
https://doaj.org/article/6faa857d6ef441bdb3a0886d6b37c265
Autor:
Robyn T. Domsic, Robin Pokrzywinski, Larissa Stassek, Wade W. Benton, Christa‐Lynn Vampola, Daniel E. Furst, Lorinda Chung, Virginia Steen, Maureen D. Mayes, Ami A. Shah, Jerry A. Molitor, Kelly Oliver, Vivek Nagaraja, Dinesh Khanna
Publikováno v:
ACR Open Rheumatology, Vol 5, Iss 3, Pp 132-141 (2023)
Objective To better understand the symptoms and impacts of Raynaud phenomenon (RP) in patients with systemic sclerosis (SSc) and to evaluate the content validity and usability of a new electronic patient‐reported outcome (PRO) measure for RP: the R
Externí odkaz:
https://doaj.org/article/2dd35a0153c940ee986f4d2a8674ad51
Autor:
Andrea Rubbert-Roth, Daniel E. Furst, Stefano Fiore, Amy Praestgaard, Vivian Bykerk, Clifton O. Bingham, Christina Charles-Schoeman, Gerd Burmester
Publikováno v:
Arthritis Research & Therapy, Vol 24, Iss 1, Pp 1-11 (2022)
Abstract Background Anemia is common in patients with rheumatoid arthritis (RA). Higher hemoglobin (Hb) levels may be associated with better clinical outcomes and patient-reported outcomes (PROs). To assess this hypothesis, we conducted two post hoc
Externí odkaz:
https://doaj.org/article/2297141dda5546b58a1730ec37efc1ff
Publikováno v:
ACR Open Rheumatology, Vol 4, Iss 3, Pp 247-253 (2022)
Objective The study objective was to conduct a systematic literature review (SLR) of ultrasound of the skin in patients with systemic sclerosis (SSc) to establish the degree to which ultrasound of the skin has been validated, using the Outcome Measur
Externí odkaz:
https://doaj.org/article/ced9af3d94a94110a398a6c7eca501af
Autor:
Yukai Wang, Xuezhen Xie, Shaoyu Zheng, Guangzhou Du, Shaoqi Chen, Weijin Zhang, Jinghua Zhuang, Jianqun Lin, Shijian Hu, Kedi Zheng, Angelina Mikish, Zhuangyong Xu, Guohong Zhang, Luna Gargani, Cosimo Bruni, Anna-Maria Hoffmann-Vold, Marco Matucci-Cerinic, Daniel E. Furst
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
ObjectiveTo investigate the role of serum B-cell activating factor (BAFF) and lung ultrasound (LUS) B-lines in connective tissue disease related interstitial lung disease (CTD-ILD), and their association with different ILD patterns on high resolution
Externí odkaz:
https://doaj.org/article/f5971884b042444daad8fd035327f73e